10x Genomics (TXG) Short term Debt (2018 - 2019)
10x Genomics recorded quarterly Short term Debt of $9.9 million in Q4 2019, up 33.85% quarter-over-quarter from $7.4 million in Q3 2019, and up 136.02% year-over-year from $4.2 million in Q4 2018.
10x Genomics' Short term Debt history runs 2 years deep, the most recent figure standing at $9.9 million for Q4 2019.
- In Q4 2019, Short term Debt rose 136.02% year-over-year to $9.9 million; the TTM figure through Dec 2019 stood at $9.9 million (up 136.02% YoY), while the FY2019 annual figure was $9.9 million, up 136.02% from the prior year.
- Short term Debt came in at $9.9 million for Q4 2019 at 10x Genomics, up from $7.4 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $9.9 million in Q4 2019 to a low of $4.2 million in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Teladoc Health | 1.42 Bn | 672.39 Mn | 562.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 9.88 Mn |
| Sep 30, 2019 | 7.38 Mn |
| Dec 31, 2018 | 4.19 Mn |